Institutional shares held 31 Million
323K calls
582K puts
Total value of holdings $157M
$1.63M calls
$2.94M puts
Market Cap $555M
103,007,000 Shares Out.
Institutional ownership 30.12%
# of Institutions 135


Latest Institutional Activity in HUMA

Top Purchases

Q3 2024
Wealth Effects LLC Shares Held: 64.2K ($346K)
Q3 2024
Raymond James & Associates Shares Held: 43.3K ($233K)
Q3 2024
Commonwealth Equity Services, LLC Shares Held: 65.5K ($353K)
Q3 2024
Sg Americas Securities, LLC Shares Held: 32.1K ($173K)
Q3 2024
Total Clarity Wealth Management, Inc. Shares Held: 29.2K ($157K)

Top Sells

Q3 2024
Ars Investment Partners, LLC Shares Held: 84.4K ($455K)
Q3 2024
New York State Common Retirement Fund Shares Held: 15.2K ($82K)
Q3 2024
N Verses Capital, LLC Shares Held: 4.5K ($24.3K)
Q3 2024
Principal Securities, Inc. Shares Held: 500 ($2.7K)
Q3 2024
Nisa Investment Advisors, LLC Shares Held: 164 ($884)

About HUMA

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.


Insider Transactions at HUMA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
344K Shares
From 10 Insiders
Open market or private purchase 122K shares
Exercise of conversion of derivative security 222K shares
Sell / Disposition
6.16M Shares
From 5 Insiders
Open market or private sale 6.16M shares

Track Institutional and Insider Activities on HUMA

Follow Humacyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HUMA shares.

Notify only if

Insider Trading

Get notified when an Humacyte, Inc. insider buys or sells HUMA shares.

Notify only if

News

Receive news related to Humacyte, Inc.

Track Activities on HUMA